|
The studies that show no survival benefit based on routine scanning (for early stage bc) are all pre-Herceptin and lots of other new targeted treatment options-- gamma knife, etc. I can't help but wonder if that with all the new Her2 therapies, these studies are outdated.
That said, my Onc doesn't do routine scans, and I'm in no hurry to get them. But the argument that 'studies show...blah blah' is not an argument. At this point, I think it would be better to say 'we don't know' and should be subject of further study.
Jen
__________________
dx 4/05 @ 34 y.o.
Stage IIIC, ER+ (90%)/PR+ (95%)/HER2+ (IHC 3+)
lumpectomy-- 2.5 cm 15+/37 nodes
(IVF in between surgery and chemo)
tx dd A/C, followed by dd Taxol & Herceptin
30 rads (or was it 35?)
Finished Herceptin on 7/24/06
Tamox
livingcured.blogspot.com
"Keep your face to the sunshine and you cannot see the shadow." -- Helen Keller
|